Literature DB >> 22897422

The Hypertension in the Very Elderly Trial - latest data.

Omar Mukhtar1, Stephen H D Jackson.   

Abstract

Early trials in the field of hypertension focused on adults in their fifties and sixties. However, with the passage of time, a progressive effort has been made to expand the evidence base for treatment in older adults. 2008 saw publication of data from the Hypertension in the Very Elderly Trial which demonstrated significant mortality and morbidity benefits from antihypertensive therapy in octogenarians. More recently, additional data from this cohort has been published suggesting that appropriate anti-hypertensive therapy may lead to a reduction in incident cognitive impairment and fractures, whilst a 1 year open label extension of the main study confirmed many of the original trial findings. This review provides an overview of the Hypertension in the Very Elderly Trial whilst also discursively evaluating the latest data.
© 2012 The Authors. British Journal of Clinical Pharmacology © 2012 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22897422      PMCID: PMC3612712          DOI: 10.1111/j.1365-2125.2012.04427.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  24 in total

1.  Treating very elderly hypertensive patients is rewarding: the HYVET results.

Authors:  Giuseppe Mancia; Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

2.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

3.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

4.  The effect of treatment based on a diuretic (indapamide) +/- ACE inhibitor (perindopril) on fractures in the Hypertension in the Very Elderly Trial (HYVET).

Authors:  Ruth Peters; Nigel Beckett; Lisa Burch; Marie-Christine de Vernejoul; Lisheng Liu; Joe Duggan; Cameron Swift; Blas Gil-Extremera; Astrid Fletcher; Christopher Bulpitt
Journal:  Age Ageing       Date:  2010-06-23       Impact factor: 10.668

5.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

6.  Association of depression with subsequent mortality, cardiovascular morbidity and incident dementia in people aged 80 and over and suffering from hypertension. Data from the Hypertension in the Very Elderly Trial (HYVET).

Authors:  Ruth Peters; Elisabete Pinto; Nigel Beckett; Cameron Swift; John Potter; Terry McCormack; Maria Nunes; John Grimley-Evans; Astrid Fletcher; Christopher Bulpitt
Journal:  Age Ageing       Date:  2010-05-23       Impact factor: 10.668

7.  Results of the pilot study for the Hypertension in the Very Elderly Trial.

Authors:  Christopher J Bulpitt; Nigel S Beckett; Jonathan Cooke; Dan L Dumitrascu; Blas Gil-Extremera; Choudomir Nachev; Maria Nunes; Ruth Peters; Jan A Staessen; Lut Thijs
Journal:  J Hypertens       Date:  2003-12       Impact factor: 4.844

8.  Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group.

Authors: 
Journal:  JAMA       Date:  1979-12-07       Impact factor: 56.272

9.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.

Authors:  Ruth Peters; Nigel Beckett; Francoise Forette; Jaakko Tuomilehto; Robert Clarke; Craig Ritchie; Adam Waldman; Ivan Walton; Ruth Poulter; Shuping Ma; Marius Comsa; Lisa Burch; Astrid Fletcher; Christopher Bulpitt
Journal:  Lancet Neurol       Date:  2008-07-07       Impact factor: 44.182

10.  Sociodemographic and lifestyle risk factors for incident dementia and cognitive decline in the HYVET.

Authors:  Ruth Peters; Nigel Beckett; Mariela Geneva; Maria Tzekova; Fang Hong Lu; Ruth Poulter; Nicola Gainsborough; Brian Williams; Marie-Christine de Vernejoul; Astrid Fletcher; Christopher Bulpitt
Journal:  Age Ageing       Date:  2009-06-24       Impact factor: 10.668

View more
  3 in total

Review 1.  Prevention and Treatment of Acute Stroke in the Nonagenarians and Beyond: Medical and Ethical Issues.

Authors:  Tiberiu A Pana; Jesus A Perdomo-Lampignano; Phyo K Myint
Journal:  Curr Treat Options Neurol       Date:  2019-05-08       Impact factor: 3.598

2.  Antihypertensive Medications, Loop Diuretics, and Risk of Hip Fracture in the Elderly: A Population-Based Cohort Study of 81,617 Italian Patients Newly Treated Between 2005 and 2009.

Authors:  Giovanni Corrao; Paolo Mazzola; Matteo Monzio Compagnoni; Federico Rea; Luca Merlino; Giorgio Annoni; Giuseppe Mancia
Journal:  Drugs Aging       Date:  2015-11       Impact factor: 3.923

3.  Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction.

Authors:  Edna Grünblatt; Jasmin Bartl; Diana-Iulia Iuhos; Ana Knezovic; Vladimir Trkulja; Peter Riederer; Susanne Walitza; Melita Salkovic-Petrisic
Journal:  J Mol Psychiatry       Date:  2015-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.